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Abstract V-1 acts as a positive and coordinate regulator of
gene expression of catecholamine biosynthetic enzymes in
PC12D cells. The present study was conducted to investigate
the mechanism controlling expression of V-1 in the adrenal
gland. Immunohistochemical analysis demonstrated that norad-
renergic chroma⁄n cells more highly expressed V-1 than adren-
ergic chroma⁄n cells preferentially expressing the glucocorti-
coid receptor in rat adrenal glands. Western blotting showed
that in cultured bovine adrenal medullary cells, dexamethasone,
a synthetic glucocorticoid, inhibited expression of V-1, and that
this inhibition was prevented by RU-486, a glucocorticoid re-
ceptor antagonist. These results suggest that adrenal expression
of V-1 is di¡erentially controlled by glucocorticoids through the
speci¢c receptor, and that thereby V-1 regulates catecholamine
biosynthesis in a catecholaminergic phenotype-dependent
manner. - 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Catecholamines (dopamine, noradrenaline and adrenaline)
play multiple crucial roles as neurotransmitters and hormones
in the nervous and endocrine systems, respectively [1]. Cate-
cholamines are synthesized by the cooperative actions of four
enzymes for catecholamine biosynthesis : tyrosine hydroxylase
(TH), aromatic L-amino acid decarboxylase (AADC), dopa-
mine L-hydroxylase (DBH), and phenylethanolamine N-meth-
yltransferase (PNMT) [1]. However, the molecular mechanism
which controls the coordinate expression of four catechol-
amine biosynthetic enzymes in a transmitter phenotype-depen-
dent manner remains to be elucidated.
V-1 is a novel soluble protein consisting of 117 amino acids
that contains 2.5 tandem repeats of the cdc10/SWI6 motif,
also known as the ankyrin repeat [2,3]. We have recently
shown that overexpression of V-1 elicits the coordinate up-
regulation of TH, AADC, and DBH mRNA in the neuronal
cell line PC12D, and consequently, dopamine and noradren-
aline levels are increased [4,5], suggesting the possible involve-
ment of V-1 in phenotype-dependent transcriptional regula-
tion of the catecholamine biosynthetic enzymes in vivo.
V-1 is expressed in the chroma⁄n cells of rat adrenal me-
dulla [4], which consists of two major subpopulations: adren-
ergic and noradrenergic chroma⁄n cells. We more recently
found that expression of V-1 in noradrenergic chroma⁄n cells
was higher than that in adrenergic chroma⁄n cells of rat
adrenal gland by immunohistochemistry. It is well-known
that the adrenal medulla PNMT activity requires the high
levels of glucocorticoids received from the cortex [6]. Gluco-
corticoid receptor appears to be to a large extent con¢ned to
PNMT-positive adrenergic cells in the adrenal medulla [7]. In
the present study, to examine whether glucocorticoid a¡ects
expression of V-1 in the adrenal chroma⁄n cells, we analyzed
the e¡ect of glucocorticoid on expression of V-1 in cultured
bovine adrenal medullary cells. Other intrinsic factors control-
ling the adrenal expression of V-1 will be also discussed. Here
we describe the ¢rst evidence that glucocorticoid acts as a
negative regulator of expression of V-1 in the cultured adrenal
medullary cells.
2. Materials and methods
2.1. Immunohistochemistry
Adult Wistar rats were deeply anesthetized with pentobarbiturate
and ¢xed by intracardiac perfusion with 4% paraformaldehyde in
0.1 M phosphate-bu¡ered saline, pH 7.4 (PBS), and the adrenal
glands were removed and immersed in the same solution for an addi-
tional 6 h. After dipping overnight with PBS containing 30% sucrose,
tissues were quickly frozen in liquid nitrogen, and 20-Wm-thick sec-
tions were made on a cryostat. Sections were mounted on glass slides
and ¢rst observed under a £uorescence microscope for detection of
catecholamines as previously described [8,9,10]. Following taking mi-
crophotographs of the £uorescent cells, immunohistochemistry using
anti-V-1 antibody was performed as described previously [4], except
that sections were stained by a successive incubation with the primary
antibody at a concentration of 0.5 Wg/ml and the biotinylated anti-
rabbit IgG and streptoavidin-peroxidase (Histo¢ne kit, Nichirei).
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2.2. Primary culture of bovine adrenal medullary cells
Bovine adrenal cells were isolated as previously reported [11,12].
For Western blotting of the time course for expression of V-1 and
catecholamine biosynthetic enzymes in the cells in culture, cells were
cultured for one week, as previously described [11,12]. For analysis of
the e¡ect of glucocorticoids on expression of V-1, cells were cultured
in the presence or absence of 1 WM dexamethasone and/or 1 and 10
WM RU-486 for 2 or 3 days.
2.3. Cell extract preparation
Cells were lysed in RIPA bu¡er (0.15 M NaCl, 1% Nonident P-40,
0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris^HCl, pH 8.0),
including protease inhibitors and phosphatase inhibitors, and centri-
fuged at 14 000 rpm for 20 min. The resultant supernatants were used
as cell extracts for Western blotting. Protein concentration was deter-
mined using Bio-Rad protein assay reagent (Bio-Rad).
2.4. Western blotting
Cell extracts were separated by SDS^polyacrylamide gel electropho-
resis and transferred to polyvinylidene di£uoride (Bio-Rad) or nitro-
cellulose membranes (Schleicher and Schuell). The extracts were ana-
lyzed by Western blotting with anti-V-1 antibody, anti-TH antibody
(Eugene Tech International), anti-AADC antibody (Signal Transduc-
tion) and anti-DBH antibody (Signal Transduction). The blotted
membrane was blocked in 5% or 10% skim milk in TBT bu¡er
(0.15 M NaCl, 0.05% or 0.1% (v/v) Tween 20, 10 mM Tris^HCl pH
7.6) for 1 h at room temperature. The membrane was thereafter in-
cubated successively with primary antibodies in 5% or 10% skim milk/
TBT overnight at 4‡C and horseradish peroxidase conjugated protein
A or anti-sheep IgG for 1 h at room temperature. Following stripping
the antibody from the blots, the blots were reprobed with anti-14-3-3L
protein antibody (sc-628, Santa Cruz Biotechnology). Immunoreactiv-
ity was visualized with enhanced chemiluminescence detection re-
agents (Pierce) and the immunoreactive signals were quanti¢ed using
a densitometer (ATTO Densitograph).
Fig. 1. Di¡erential expression of V-1 in adrenergic and noradrenergic chroma⁄n cells of rat adrenal medulla revealed by immunohistochemis-
try. a: Left, the sections of rat adrenal glands stained by anti-V-1 antibody; right, higher magni¢cation of cells in the same section. Small-sized
chroma⁄n cells [23] indicated by asterisks are more intensely immunopositive. C: cortex, M: medulla. b: Chroma⁄n cells exhibiting more in-
tense immunoreactivity for V-1 (asterisks in upper panel) are identi¢ed as £uorescent noradrenergic cells (lower panel) under a £uorescence
microscope. Scale bar= 20 Wm.
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3. Results
3.1. Di¡erential expression of V-1 in adrenergic and
noradrenergic chroma⁄n cells of rat adrenal medulla
We have recently reported the localization of expression of
V-1 in rat adrenal medullary chroma⁄n cells [4]. We analyzed
in more detail expression of V-1 in adrenergic and noradren-
ergic chroma⁄n cells of the adrenal gland by immunohisto-
chemistry combined with the procedure for detection of cat-
echolamines. As shown in Fig. 1, immunohistochemical
analyses revealed that both the adrenergic and noradrenergic
chroma⁄n cells expressed V-1, but £uorescent noradrenergic
chroma⁄n cells expressed V-1 more intensely than the adren-
ergic cells.
3.2. Down-regulated expression of V-1 followed by a decrease
in expression of TH and DBH in bovine adrenal medullary
cells in culture
Anti-V-1 antibody utilized for the present study speci¢cally
recognized a single 12 kDa protein band in the extract of
cultured bovine medullary cells, of which the molecular size
corresponded to that of rat V-1 protein as previously reported
(data not shown). We thus concluded that this immunoreac-
tive protein with 12 kDa was bovine V-1 protein. To examine
the functional role of V-1 in the regulation of expression of
catecholamine biosynthetic enzymes, we ¢rst analyzed expres-
sion of V-1, TH, AADC and DBH proteins in bovine adrenal
medullary cells in culture by Western blotting. When the cells
were cultured for one week, TH and DBH proteins were
markedly decreased between 3 and 5 days in culture, while
expression of AADC protein appeared to change little (Fig.
2). On the other hand, expression of V-1 steeply decreased
Fig. 2. Changes in expression of V-1 and the catecholamine biosyn-
thetic enzymes in cultured bovine adrenal medullary cells. The iso-
lated adrenal medulla cells were cultured for the indicated times.
Proteins of cell extracts were resolved on 18% and 10% SDS^poly-
acrylamide gels for analyses of expression of V-1, TH, AADC,
DBH and 14-3-3L (internal control) proteins by Western blotting.
Immunoreactive bands of TH, AADC and DBH proteins expectedly
showed molecular weight of 60 kDa, 56 kDa and 75 kDa, respec-
tively. Similar results were obtained in two independent experi-
ments.
Fig. 3. E¡ect of dexamethasone (Dex) on expression of V-1 in the
cultured cells. a: Cells were untreated (Control) or treated with
1 WM Dex for 2^3 days. Proteins of cell extracts were separated on
18% SDS^polyacrylamide gels for Western blotting of expression of
V-1 and 14-3-3L (internal control) proteins. b: The histogram indi-
cates the protein levels of V-1. Values denote the meansRS.E.M.
(n=3). Statistical analyses were performed by unpaired t-test. Sig-
ni¢cant di¡erences from control are indicated at **P6 0.01.
c: Changes in expression of V-1 in the cells cultured in the absence
or presence of Dex and/or with RU-486. The cells were treated with
the indicated concentrations of these drugs for 2^3 days. Cell ex-
tracts were separated on 18% SDS^polyacrylamide gels for Western
blotting. Shown are representative expression patterns (n=2).
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between 1 and 3 days in culture, and thereafter the expression
level was almost sustained except for a slight increase at 5 days
in culture.
3.3. Inhibition of V-1 expression by glucocorticoid
The observations obtained by immunohistochemistry raises
the possibility that glucocorticoids negatively regulate expres-
sion of V-1. Next we tested whether glucocorticoids inhibit
expression of V-1 in cultured bovine adrenal medullary cells.
The cultured cells were treated with 1 WM dexamethasone, a
synthetic glucocorticoid, and/or 1 WM or 10 WM of RU-486, a
glucocorticoid receptor antagonist. Western blotting showed
that expression of V-1 in the cells treated with 1 WM dexame-
thasone decreased to approximately 50% of that of the un-
treated cells (Fig. 3a,b). This decrease in expression of V-1 by
1 WM dexamethasone was blocked by 10 WM RU-486, while
at 1 WM, this inhibitor did not e¡ectively antagonize the in-
hibitory action of dexamethasone (Fig. 3c).
4. Discussion
This study is the ¢rst to demonstrate that glucocorticoid
inhibits expression of V-1, an ankyrin repeat protein having
a catecholamine biosynthesis-promoting activity, in bovine
adrenal medullary cells in culture. Consistent with the data
on the inhibitory action of dexamethasone on expression of
V-1, the present immunohistochemistry revealed that in rat
adrenal gland, V-1 was more intensely expressed in the norad-
renergic chroma⁄n cells than in the adrenergic chroma⁄n
cells, to which glucocorticoid receptor appeared to be to a
large extent restricted [7]. Furthermore, we evidently showed
that an apparent decrease in expression of V-1 preceded a
remarkable reduction in those of TH and DBH proteins in
the adrenal medullary cells in culture.
The present immunohistochemical data showed that, in rat
adrenal gland, noradrenergic but not adrenergic chroma⁄n
cells preferentially expressed V-1. Expression of GAP-43, a
neuron-speci¢c gene product, has been shown to be negatively
regulated by glucocorticoids in PC12 cell [13]. This protein
has been also reported to be exclusively localized in noradre-
nergic chroma⁄n cells in the postnanal rat adrenal gland [14].
Unlike GAP-43, V-1 is localized in both noradrenergic and
adrenergic chroma⁄n cell subpopulations in rat adrenal
gland, but the noradrenergic cell subpopulation preferentially
expresses V-1. Like rat, mouse exhibited such a preferential
expression of V-1 in the adrenal gland (unpublished observa-
tions). Therefore it is fairly plausible to consider that V-1 acts
in both the catecholaminergic cell subpopulations. Taken to-
gether with our previous data obtained from the overexpres-
sion experiment of V-1 gene in PC12D cells [4], the ¢ndings of
the present immunohistochemical study suggest that V-1 con-
trols the regulation of catecholamine biosynthesis in both nor-
adrenergic and adrenergic chroma⁄n cells of the adrenal
gland.
It has previously been shown that bovine adrenal medullary
cells show progressive losses of catecholamine content and the
biosynthetic enzyme activities in culture [15]. In this study,
our results consistently revealed that bovine adrenal medul-
lary cells exhibited a dramatic reduction in expression of TH
and DBH proteins between 3 and 5 days in culture after these
cells remarkably decreased expression of V-1 between 1 and
3 days in culture. It was also observed that the total catechol-
amine content of the cells was apparently decreased between
3 and 5 days in culture (unpublished data). From the fact that
the time course for the reduction in expression of V-1 was
earlier than that of expression of TH and DBH proteins in
the cultured cell, it is conceivable that V-1 may act upstream
of the regulatory mechanism of expression of these enzymes,
and that the down-regulation of their expression may be a
consequence of the reduction in expression of V-1. It is there-
fore possible to interpret that V-1 participates in the positive
regulation of the expression of genes encoding TH and DBH
to promote catecholamine biosynthesis. In support of this
interpretation, we have recently found that stable overexpres-
sion of V-1 stimulates expression of mRNA for TH, AADC
and DBH in PC12D cells to increase the contents of dopa-
mine and noradrenaline [4]. These results of the present study
strengthen the notion that V-1 up-regulates expression of
genes encoding catecholamine biosynthetic enzymes, although
how the expression of these genes is regulated by V-1 remains
to be clari¢ed.
Glucocorticoids are secreted in the adrenal medulla to reg-
ulate PNMT mRNA level [16], and expression of PNMT is
induced in cultured chroma⁄n cells treated with glucocorti-
coids [17]. A quite important ¢nding in this study is that
expression of V-1 is markedly decreased in the cultured cells
treated with dexamethasone as compared with untreated cells,
and that the inhibition of expression of V-1 by dexamethasone
is blocked by treatment with a glucocorticoid receptor antag-
onist, RU-486. The glucocorticoid receptor has been reported
to participate in negative regulation of action of transcription
factors such as AP-1 and NF-UB [18,19,20]. Although the
mechanism by which glucocorticoids inhibit expression of
the V-1 gene in the cultured adrenal medullary cells has not
been yet elucidated, these ¢ndings indicate that expression of
V-1 in the cultured cells is inhibited by glucocorticoid via the
speci¢c receptor. It is thus suggested that expression of V-1 in
the medullary chroma⁄n cells is under negative control by
glucocorticoids originating from the cortex in the adrenal
gland.
It is of interest that despite no addition of glucocorticoid to
culture medium, expression of V-1 in the adrenal medullary
cells was decreased during cell culture for 1 to 3 days (Fig. 2).
This result is inconsistent with that glucocorticoids regulate
negatively expression of V-1 via the speci¢c receptor (Fig. 3),
because adrenal medulla is usually in£uenced by endogenous
glucocorticoids from adrenal cortex in vivo. Therefore, be-
sides a negative regulation of expression of V-1 gene by glu-
cocorticoids, this gene may be positively controlled by other
intrinsic factors in adrenal chroma⁄n cells, i.e. splanchnic
nerves and/or peptidergic neurons that release acetylcholine
and several neuropeptides such as vasoactive intestinal poly-
peptide and pituitary adenylate cyclase activating polypeptide
[21]. Indeed, these neurons exert a positive e¡ect on cAMP
production in the chroma⁄n cells via activation of nicotinic
acetylcholine receptors in vivo [22]. Forskolin, a stimulator of
adenylate cyclase responsible for cAMP production, elevated
the expression of V-1 in PC12D cells (unpublished data).
Therefore, an attractive interpretation of a reduction in ex-
pression of V-1 in adrenal medullary cells cultured in the
absence of glucocorticoid is that this reduction in expression
of V-1 in the cultured cells is due to a lack of a transsynaptic
positive regulation of V-1 gene by splanchnic or peptidergic
neurons.
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